Diabetic retinopathy (DR) is an important cause of avoidable blindness worldwide. Seventy percent of diabetes occur in low and lower-middle income countries. Clinical practice guidelines for the ...

Many diabetic retinopathy patients don't experience noticeable vision changes until the condition progresses significantly. Many diabetic retinopathy patients don’t experience noticeable vision ...

Women with chronic diabetes should undergo a retinopathy screening early in pregnancy. Anti-VEGF drug labels recommend against use in pregnant women. KOLOA, Hawaii — Patients with diabetic ...

"Empagliflozin could be beneficial in slowing down progression to more advanced stages of diabetic ... (mean age 65.6, 52.4% men, 75% white). For the diabetic retinopathy progression analysis ...

An estimated 3 million Indians are at risk of losing their vision due to the country's 12.5% incidence of diabetic retinopathy and 4% of vision ... symptoms in the early stages of diabetic ...

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors. Methods: 199 type 2 ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.